The present invention relates to a novel composition and method to potentiate the antitumor effect of an oncolytic virus by providing for resistance against a hosts innate interferon response. Particularly, a B18R gene is incorporated into an oncolytic virus. During treatment of a host with the modified oncolytic virus, the oncolytic virus retains its phenotype, and the hosts innate immune response has a minimal affect on viral replication.